Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.3.1.900
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Operating expenses:      
Research and development $ 6,587,183 $ 12,240,535 $ 8,914,084
General and administrative 4,422,764 4,875,030 4,020,364
Loss from operations (11,009,947) (17,115,565) (12,934,448)
Other income (expense)      
Change in fair value of warrant liability, unit purchase option liability and investor rights obligation 1,313,049 2,266,161 (121,115)
Interest income (expense), net (793,205) (1,206,187) 10,555
Total other income (expense) 519,844 1,059,974 (110,560)
Net loss (10,490,103) (16,055,591) (13,045,008)
Net loss attributable to common stockholders $ (10,490,103) $ (3,521,153) $ (13,126,972)
Net loss per share of common stock, basic and diluted $ (4.71) $ (5.48) $ (20.72)
Weighted average shares of Common Stock outstanding, basic and diluted 2,226,023 642,052 633,669